Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 2,026 | 3,355 | 2,437 | 2,306 | 2,460 |
| Operating Income | -2,026 | -3,355 | -2,437 | -2,306 | -2,460 |
| Interest Expense | 199 | 11 | 10 | 2 | 7 |
| Other Income | 8 | 17 | -16 | 3 | 16 |
| Pre-tax Income | -2,217 | -3,349 | -2,463 | -2,305 | -2,451 |
| Net Income Continuous | -2,217 | -3,349 | -2,463 | -2,305 | -2,451 |
| Net Income | $-2,217 | $-3,349 | $-2,463 | $-2,305 | $-2,451 |
| EPS Basic Total Ops | -3.65 | -0.27 | -11.32 | -15.27 | -21.02 |
| EPS Basic Continuous Ops | -3.65 | -0.20 | -11.30 | -15.27 | -21.05 |
| EPS Diluted Total Ops | -3.65 | -0.27 | -11.32 | -15.27 | -21.02 |
| EPS Diluted Continuous Ops | -3.65 | -0.20 | -11.30 | -15.27 | -21.05 |
| EPS Diluted Before Non-Recurring Items | -3.60 | -3.30 | -11.41 | N/A | N/A |
| EBITDA(a) | $-1,833 | $-3,355 | $-2,437 | $-2,306 | $-2,460 |